Cantor Fitzgerald Sets a Buy Rating on ACAD . Article.
Locialized USA 18 hours ago
ACADIA Pharmaceuticals Receives New Coverage from Analysts at Cantor Fitzgerald (ACAD)
Posted by LUSA Staff on Mar 12th, 2013 // No Comments
ACADIA Pharmaceuticals logo Analysts at Cantor Fitzgerald initiated coverage on shares of ACADIA Pharmaceuticals (NASDAQ: ACAD) in a research report issued to clients and investors on Tuesday. The firm set a “buy” rating on the stock.